@article{ref1,
title="Validation of a modified FRAX® tool for improving outpatient efficiency-part of the "Catch Before a Fall" initiative",
journal="Archives of osteoporosis",
year="2015",
author="Parker, Simon and Ciaccio, Maria and Cook, Erica and Davenport, Graham and Cooper, Alun and Grange, Simon and Smitham, Peter",
volume="10",
number="1",
pages="e230-e230",
abstract="UNLABELLED: We have validated our touch-screen-modified FRAX® tool against the traditional healthcare professional-led questionnaire, demonstrating strong concordance between doctor- and patient-derived results. We will use this in outpatient clinics and general practice to increase our capture rate of at-risk patients, making valuable use of otherwise wasted patient waiting times. <br><br>INTRODUCTION: Outpatient clinics offer an opportunity to collect valuable health information from a captive population. We have previously developed a modified fracture risk assessment (FRAX®) tool, enabling patients to self-assess their osteoporotic fracture risk in a touch-screen computer format and demonstrated its acceptability with patients. We aim to validate the accuracy of our tool against the traditional questionnaire. <br><br>METHODS: Fifty patients over 50 years of age within the fracture clinic independently completed a paper equivalent of our touch-screen-modified FRAX® questionnaire. Responses were analysed against the traditional healthcare professional (HCP)-led questionnaire which was carried out afterwards. Correlation was assessed by sensitivity, specificity, Cohen's kappa statistic and Fisher's exact test for each potential FRAX® outcome of &quot;treat&quot;, &quot;measure BMD&quot; and &quot;lifestyle advice&quot;. <br><br>RESULTS: Age range was 51-98 years. The FRAX® tool was completed by 88 % of patients; six patients lacked confidence in estimating either their height or weight. Following question adjustment according to patient response and feedback, our tool achieved >95 % sensitivity and specificity for the &quot;treat&quot; and &quot;lifestyle advice&quot; groups, and 79 % sensitivity and 100 % specificity in the &quot;measure BMD&quot; group. Cohen's kappa value ranged from 0.823 to 0.995 across all groups, demonstrating &quot;very good&quot; agreement for all. Fisher's exact test demonstrated significant concordance between doctor and patient decisions. <br><br>DISCUSSION: Our modified tool provides a simple, accurate and reliable method for patients to self-report their own FRAX® score outside the clinical contact period, thus releasing the HCP from the time required to complete the questionnaire and potentially increasing our capture rate of at-risk patients.<p /> <p>Language: en</p>",
language="en",
issn="1862-3522",
doi="10.1007/s11657-015-0230-7",
url="http://dx.doi.org/10.1007/s11657-015-0230-7"
}